<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39308856</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>23</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>24</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1664-3224</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Frontiers in immunology</Title><ISOAbbreviation>Front Immunol</ISOAbbreviation></Journal><ArticleTitle>RNA editing in response to COVID-19 vaccines: unveiling dynamic epigenetic regulation of host immunity.</ArticleTitle><Pagination><StartPage>1413704</StartPage><MedlinePgn>1413704</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1413704</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fimmu.2024.1413704</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">COVID-19 vaccines are crucial for reducing the threat and burden of the pandemic on global public health, yet the epigenetic, especially RNA editing in response to the vaccines remains unelucidated.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Our current study performed an epitranscriptomic analysis of RNA-Seq data of 260 blood samples from 102 healthy and SARS-CoV-2 naïve individuals receiving different doses of the COVID-19 vaccine and revealed dynamic, transcriptome-wide adenosine to inosine (A-to-I) RNA editing changes in response to COVID-19 vaccines (RNA editing in response to COVID-19 vaccines). 5592 differential RNA editing (DRE) sites in 1820 genes were identified, with most of them showing up-regulated RNA editing and correlated with increased expression of edited genes. These deferentially edited genes were primarily involved in immune- and virus-related gene functions and pathways. Differential <i>ADAR</i> expression probably contributed to RNA editing in response to COVID-19 vaccines. One of the most significant DRE in RNA editing in response to COVID-19 vaccines was in apolipoprotein L6 (<i>APOL6</i>) 3' UTR, which positively correlated with its up-regulated expression. In addition, recoded key antiviral and immune-related proteins such as IFI30 and GBP1 recoded by missense editing was observed as an essential component of RNA editing in response to COVID-19 vaccines. Furthermore, both RNA editing in response to COVID-19 vaccines and its functions dynamically depended on the number of vaccine doses.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">Our results thus underscored the potential impact of blood RNA editing in response to COVID-19 vaccines on the host's molecular immune system.</AbstractText><CopyrightInformation>Copyright © 2024 Jin, Liang, Pan, Huang, Feng, Sui, Yu, Tang, Zhu and Chen.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jin</LastName><ForeName>Yun-Yun</ForeName><Initials>YY</Initials><AffiliationInfo><Affiliation>Laboratory of Genomic and Precision Medicine, Wuxi School of Medicine, Jiangnan University, Wuxi, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Joint Primate Research Center for Chronic Diseases, Institute of Zoology of Guangdong Academy of Science, Jiangnan University, Wuxi, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Jiangnan University Brain Institute, Jiangnan University, Wuxi, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liang</LastName><ForeName>Ya-Ping</ForeName><Initials>YP</Initials><AffiliationInfo><Affiliation>Laboratory of Genomic and Precision Medicine, Wuxi School of Medicine, Jiangnan University, Wuxi, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Joint Primate Research Center for Chronic Diseases, Institute of Zoology of Guangdong Academy of Science, Jiangnan University, Wuxi, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Jiangnan University Brain Institute, Jiangnan University, Wuxi, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pan</LastName><ForeName>Jia-Qi</ForeName><Initials>JQ</Initials><AffiliationInfo><Affiliation>Laboratory of Genomic and Precision Medicine, Wuxi School of Medicine, Jiangnan University, Wuxi, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Joint Primate Research Center for Chronic Diseases, Institute of Zoology of Guangdong Academy of Science, Jiangnan University, Wuxi, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Jiangnan University Brain Institute, Jiangnan University, Wuxi, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Wen-Hao</ForeName><Initials>WH</Initials><AffiliationInfo><Affiliation>Laboratory of Genomic and Precision Medicine, Wuxi School of Medicine, Jiangnan University, Wuxi, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Joint Primate Research Center for Chronic Diseases, Institute of Zoology of Guangdong Academy of Science, Jiangnan University, Wuxi, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Jiangnan University Brain Institute, Jiangnan University, Wuxi, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Feng</LastName><ForeName>Yan-Meng</ForeName><Initials>YM</Initials><AffiliationInfo><Affiliation>Laboratory of Genomic and Precision Medicine, Wuxi School of Medicine, Jiangnan University, Wuxi, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Joint Primate Research Center for Chronic Diseases, Institute of Zoology of Guangdong Academy of Science, Jiangnan University, Wuxi, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Jiangnan University Brain Institute, Jiangnan University, Wuxi, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sui</LastName><ForeName>Wei-Jia</ForeName><Initials>WJ</Initials><AffiliationInfo><Affiliation>Laboratory of Genomic and Precision Medicine, Wuxi School of Medicine, Jiangnan University, Wuxi, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Joint Primate Research Center for Chronic Diseases, Institute of Zoology of Guangdong Academy of Science, Jiangnan University, Wuxi, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Jiangnan University Brain Institute, Jiangnan University, Wuxi, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Han</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Laboratory of Genomic and Precision Medicine, Wuxi School of Medicine, Jiangnan University, Wuxi, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Joint Primate Research Center for Chronic Diseases, Institute of Zoology of Guangdong Academy of Science, Jiangnan University, Wuxi, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Jiangnan University Brain Institute, Jiangnan University, Wuxi, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tang</LastName><ForeName>Xiao-Dan</ForeName><Initials>XD</Initials><AffiliationInfo><Affiliation>Laboratory of Genomic and Precision Medicine, Wuxi School of Medicine, Jiangnan University, Wuxi, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Joint Primate Research Center for Chronic Diseases, Institute of Zoology of Guangdong Academy of Science, Jiangnan University, Wuxi, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Jiangnan University Brain Institute, Jiangnan University, Wuxi, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Lin</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Laboratory of Genomic and Precision Medicine, Wuxi School of Medicine, Jiangnan University, Wuxi, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Joint Primate Research Center for Chronic Diseases, Institute of Zoology of Guangdong Academy of Science, Jiangnan University, Wuxi, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Jiangnan University Brain Institute, Jiangnan University, Wuxi, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Jian-Huan</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Laboratory of Genomic and Precision Medicine, Wuxi School of Medicine, Jiangnan University, Wuxi, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Joint Primate Research Center for Chronic Diseases, Institute of Zoology of Guangdong Academy of Science, Jiangnan University, Wuxi, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Jiangnan University Brain Institute, Jiangnan University, Wuxi, Jiangsu, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Immunol</MedlineTA><NlmUniqueID>101560960</NlmUniqueID><ISSNLinking>1664-3224</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.5.4.37</RegistryNumber><NameOfSubstance UI="C000595356">ADAR protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>K72T3FS567</RegistryNumber><NameOfSubstance UI="D000241">Adenosine</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016601">RNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.5.4.4</RegistryNumber><NameOfSubstance UI="D000243">Adenosine Deaminase</NameOfSubstance></Chemical><Chemical><RegistryNumber>5A614L51CT</RegistryNumber><NameOfSubstance UI="D007288">Inosine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D017393" MajorTopicYN="Y">RNA Editing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D044127" MajorTopicYN="Y">Epigenesis, Genetic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086663" MajorTopicYN="Y">COVID-19 Vaccines</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000241" MajorTopicYN="N">Adenosine</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016601" MajorTopicYN="N">RNA-Binding Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D059467" MajorTopicYN="N">Transcriptome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000243" MajorTopicYN="N">Adenosine Deaminase</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007288" MajorTopicYN="N">Inosine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">A-to-I RNA editing</Keyword><Keyword MajorTopicYN="N">ADARs</Keyword><Keyword MajorTopicYN="N">COVID-19 vaccine</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">immune</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>4</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>23</Day><Hour>7</Hour><Minute>30</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>23</Day><Hour>7</Hour><Minute>29</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>23</Day><Hour>5</Hour><Minute>39</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39308856</ArticleId><ArticleId IdType="pmc">PMC11413487</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2024.1413704</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>V'Kovski P, Kratzel A, Steiner S, Stalder H, Thiel V. Coronavirus biology and replication: Implications for Sars-Cov-2. Nat Rev Microbiol. (2021) 19:155–70. doi: 10.1038/s41579-020-00468-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-020-00468-6</ArticleId><ArticleId IdType="pmc">PMC7592455</ArticleId><ArticleId IdType="pubmed">33116300</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryan FJ, Norton TS, McCafferty C, Blake SJ, Stevens NE, James J, et al. . A systems immunology study comparing innate and adaptive immune responses in adults to Covid-19 mrna and adenovirus vectored vaccines. Cell Rep Med. (2023) 4:100971. doi: 10.1016/j.xcrm.2023.100971</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xcrm.2023.100971</ArticleId><ArticleId IdType="pmc">PMC9935276</ArticleId><ArticleId IdType="pubmed">36871558</ArticleId></ArticleIdList></Reference><Reference><Citation>Skelly DT, Harding AC, Gilbert-Jaramillo J, Knight ML, Longet S, Brown A, et al. . Two doses of Sars-Cov-2 vaccination induce robust immune responses to emerging Sars-Cov-2 variants of concern. Nat Commun. (2021) 12:5061. doi: 10.1038/s41467-021-25167-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-25167-5</ArticleId><ArticleId IdType="pmc">PMC8371089</ArticleId><ArticleId IdType="pubmed">34404775</ArticleId></ArticleIdList></Reference><Reference><Citation>Bian S, Li L, Wang Z, Cui L, Xu Y, Guan K, et al. . Allergic reactions after the administration of covid-19 vaccines. Front Public Health. (2022) 10:878081. doi: 10.3389/fpubh.2022.878081</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2022.878081</ArticleId><ArticleId IdType="pmc">PMC9152252</ArticleId><ArticleId IdType="pubmed">35655467</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenhawt M, Abrams EM, Shaker M, Chu DK, Khan D, Akin C, et al. . The risk of allergic reaction to Sars-Cov-2 vaccines and recommended evaluation and management: A systematic review, meta-analysis, grade assessment, and international consensus approach. J Allergy Clin Immunol Pract. (2021) 9:3546–67. doi: 10.1016/j.jaip.2021.06.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaip.2021.06.006</ArticleId><ArticleId IdType="pmc">PMC8248554</ArticleId><ArticleId IdType="pubmed">34153517</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta RK, Topol EJ. Covid-19 vaccine breakthrough infections. Science. (2021) 374:1561–2. doi: 10.1126/science.abl8487</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abl8487</ArticleId><ArticleId IdType="pubmed">34941414</ArticleId></ArticleIdList></Reference><Reference><Citation>Lipsitch M, Krammer F, Regev-Yochay G, Lustig Y, Balicer RD. Sars-Cov-2 breakthrough infections in vaccinated individuals: measurement, causes and impact. Nat Rev Immunol. (2022) 22:57–65. doi: 10.1038/s41577-021-00662-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-021-00662-4</ArticleId><ArticleId IdType="pmc">PMC8649989</ArticleId><ArticleId IdType="pubmed">34876702</ArticleId></ArticleIdList></Reference><Reference><Citation>Chemaitelly H, Abu-Raddad LJ. Waning effectiveness of Covid-19 vaccines. Lancet. (2022) 399:771–3. doi: 10.1016/s0140-6736(22)00277-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0140-6736(22)00277-x</ArticleId><ArticleId IdType="pmc">PMC8871492</ArticleId><ArticleId IdType="pubmed">35219385</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldberg Y, Mandel M, Bar-On YM, Bodenheimer O, Freedman L, Haas EJ, et al. . Waning immunity after the bnt162b2 vaccine in Israel. N Engl J Med. (2021) 385:e85. doi: 10.1056/NEJMoa2114228</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2114228</ArticleId><ArticleId IdType="pmc">PMC8609604</ArticleId><ArticleId IdType="pubmed">34706170</ArticleId></ArticleIdList></Reference><Reference><Citation>Gott JM, Emeson RB. Functions and mechanisms of rna editing. Annu Rev Genet. (2000) 34:499–531. doi: 10.1146/annurev.genet.34.1.499</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.genet.34.1.499</ArticleId><ArticleId IdType="pubmed">11092837</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Giorgio S, Martignano F, Torcia MG, Mattiuz G, Conticello SG. Evidence for host-dependent rna editing in the transcriptome of Sars-Cov-2. Sci Adv. (2020) 6:eabb5813. doi: 10.1126/sciadv.abb5813</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.abb5813</ArticleId><ArticleId IdType="pmc">PMC7299625</ArticleId><ArticleId IdType="pubmed">32596474</ArticleId></ArticleIdList></Reference><Reference><Citation>Duan Y, Tang X, Lu J. Evolutionary driving forces of a-to-I editing in metazoans. Wiley Interdiscip Rev RNA. (2022) 13:e1666. doi: 10.1002/wrna.1666</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/wrna.1666</ArticleId><ArticleId IdType="pubmed">33998151</ArticleId></ArticleIdList></Reference><Reference><Citation>Emrani J, Ahmed M, Jeffers-Francis L, Teleha JC, Mowa N, Newman RH, et al. . Sars-Cov-2, infection, transmission, transcription, translation, proteins, and treatment: A review. Int J Biol Macromol. (2021) 193:1249–73. doi: 10.1016/j.ijbiomac.2021.10.172</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijbiomac.2021.10.172</ArticleId><ArticleId IdType="pmc">PMC8552795</ArticleId><ArticleId IdType="pubmed">34756970</ArticleId></ArticleIdList></Reference><Reference><Citation>Heale BS, Keegan LP, McGurk L, Michlewski G, Brindle J, Stanton CM, et al. . Editing independent effects of adars on the mirna/sirna pathways. EMBO J. (2009) 28:3145–56. doi: 10.1038/emboj.2009.244</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emboj.2009.244</ArticleId><ArticleId IdType="pmc">PMC2735678</ArticleId><ArticleId IdType="pubmed">19713932</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishikura K. Functions and regulation of rna editing by adar deaminases. Annu Rev Biochem. (2010) 79:321–49. doi: 10.1146/annurev-biochem-060208-105251</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-biochem-060208-105251</ArticleId><ArticleId IdType="pmc">PMC2953425</ArticleId><ArticleId IdType="pubmed">20192758</ArticleId></ArticleIdList></Reference><Reference><Citation>Picardi E, Mansi L, Pesole G. Detection of a-to-I rna editing in Sars-Cov-2. Genes (Basel). (2021) 13(1):41. doi: 10.3390/genes13010041</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/genes13010041</ArticleId><ArticleId IdType="pmc">PMC8774467</ArticleId><ArticleId IdType="pubmed">35052382</ArticleId></ArticleIdList></Reference><Reference><Citation>Song Y, He X, Yang W, Wu Y, Cui J, Tang T, et al. . Virus-specific editing identification approach reveals the landscape of a-to-I editing and its impacts on Sars-Cov-2 characteristics and evolution. Nucleic Acids Res. (2022) 50:2509–21. doi: 10.1093/nar/gkac120</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkac120</ArticleId><ArticleId IdType="pmc">PMC8934641</ArticleId><ArticleId IdType="pubmed">35234938</ArticleId></ArticleIdList></Reference><Reference><Citation>Crooke PS, 3rd, Tossberg JT, Porter KP, Aune TM. Reduced a-to-I Editing of Endogenous Alu Rnas in Lung after Sars-Cov-2 Infection. Curr Res Immunol. (2021) 2:52–9. doi: 10.1016/j.crimmu.2021.04.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.crimmu.2021.04.001</ArticleId><ArticleId IdType="pmc">PMC8084883</ArticleId><ArticleId IdType="pubmed">33969287</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng X, Luo Y, Li H, Guo X, Chen H, Ji X, et al. . Rna editing increases the nucleotide diversity of Sars-Cov-2 in human host cells. PLoS Genet. (2022) 18:e1010130. doi: 10.1371/journal.pgen.1010130</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1010130</ArticleId><ArticleId IdType="pmc">PMC9000099</ArticleId><ArticleId IdType="pubmed">35353808</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei ZY, Wang ZX, Li JH, Wen YS, Gao D, Xia SY, et al. . Host a-to-I rna editing signatures in intracellular bacterial and single-strand rna viral infections. Front Immunol. (2023) 14:1121096. doi: 10.3389/fimmu.2023.1121096</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2023.1121096</ArticleId><ArticleId IdType="pmc">PMC10112020</ArticleId><ArticleId IdType="pubmed">37081881</ArticleId></ArticleIdList></Reference><Reference><Citation>Tao J, Ren CY, Wei ZY, Zhang F, Xu J, Chen JH. Transcriptome-wide identification of G-to-a rna editing in chronic social defeat stress mouse models. Front Genet. (2021) 12:680548. doi: 10.3389/fgene.2021.680548</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fgene.2021.680548</ArticleId><ArticleId IdType="pmc">PMC8173075</ArticleId><ArticleId IdType="pubmed">34093668</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobin A, Gingeras TR. Mapping rna-seq reads with star. Curr Protoc Bioinf. (2015) 51:11.4.1–.4.9. doi: 10.1002/0471250953.bi1114s51</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/0471250953.bi1114s51</ArticleId><ArticleId IdType="pmc">PMC4631051</ArticleId><ArticleId IdType="pubmed">26334920</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, et al. . The sequence alignment/map format and samtools. Bioinformatics. (2009) 25:2078–9. doi: 10.1093/bioinformatics/btp352</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btp352</ArticleId><ArticleId IdType="pmc">PMC2723002</ArticleId><ArticleId IdType="pubmed">19505943</ArticleId></ArticleIdList></Reference><Reference><Citation>Van der Auwera GA, Carneiro MO, Hartl C, Poplin R, Del Angel G, Levy-Moonshine A, et al. . From fastq data to high confidence variant calls: The genome analysis toolkit best practices pipeline. Curr Protoc Bioinf. (2013) 43:11.0.1–.0.33. doi: 10.1002/0471250953.bi1110s43</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/0471250953.bi1110s43</ArticleId><ArticleId IdType="pmc">PMC4243306</ArticleId><ArticleId IdType="pubmed">25431634</ArticleId></ArticleIdList></Reference><Reference><Citation>Koboldt DC, Zhang Q, Larson DE, Shen D, McLellan MD, Lin L, et al. . Varscan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing. Genome Res. (2012) 22:568–76. doi: 10.1101/gr.129684.111</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gr.129684.111</ArticleId><ArticleId IdType="pmc">PMC3290792</ArticleId><ArticleId IdType="pubmed">22300766</ArticleId></ArticleIdList></Reference><Reference><Citation>McLaren W, Gil L, Hunt SE, Riat HS, Ritchie GR, Thormann A, et al. . The ensembl variant effect predictor. Genome Biol. (2016) 17:122. doi: 10.1186/s13059-016-0974-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13059-016-0974-4</ArticleId><ArticleId IdType="pmc">PMC4893825</ArticleId><ArticleId IdType="pubmed">27268795</ArticleId></ArticleIdList></Reference><Reference><Citation>Mansi L, Tangaro MA, Lo Giudice C, Flati T, Kopel E, Schaffer AA, et al. . Rediportal: millions of novel a-to-I rna editing events from thousands of rnaseq experiments. Nucleic Acids Res. (2021) 49:D1012–d9. doi: 10.1093/nar/gkaa916</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkaa916</ArticleId><ArticleId IdType="pmc">PMC7778987</ArticleId><ArticleId IdType="pubmed">33104797</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao Y, Smyth GK, Shi W. Featurecounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics. (2014) 30:923–30. doi: 10.1093/bioinformatics/btt656</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btt656</ArticleId><ArticleId IdType="pubmed">24227677</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y, Pan Q, Pires DEV, Rodrigues CHM, Ascher DB. Ddmut: predicting effects of mutations on protein stability using deep learning. Nucleic Acids Res. (2023) 51:W122–w8. doi: 10.1093/nar/gkad472</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkad472</ArticleId><ArticleId IdType="pmc">PMC10320186</ArticleId><ArticleId IdType="pubmed">37283042</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuleshov MV, Jones MR, Rouillard AD, Fernandez NF, Duan Q, Wang Z, et al. . Enrichr: A comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Res. (2016) 44:W90–7. doi: 10.1093/nar/gkw377</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkw377</ArticleId><ArticleId IdType="pmc">PMC4987924</ArticleId><ArticleId IdType="pubmed">27141961</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Guo X, Li C, Kou Z, Lin L, Yao M, et al. . Transcriptome analysis of peripheral blood mononuclear cells in Sars-Cov-2 naïve and recovered individuals vaccinated with inactivated vaccine. Front Cell Infect Microbiol. (2021) 11:821828. doi: 10.3389/fcimb.2021.821828</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2021.821828</ArticleId><ArticleId IdType="pmc">PMC8851474</ArticleId><ArticleId IdType="pubmed">35186784</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor DR, Puig M, Darnell ME, Mihalik K, Feinstone SM. New antiviral pathway that mediates hepatitis C virus replicon interferon sensitivity through adar1. J Virol. (2005) 79:6291–8. doi: 10.1128/jvi.79.10.6291-6298.2005</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.79.10.6291-6298.2005</ArticleId><ArticleId IdType="pmc">PMC1091666</ArticleId><ArticleId IdType="pubmed">15858013</ArticleId></ArticleIdList></Reference><Reference><Citation>Garaigorta U, Chisari FV. Hepatitis C virus blocks interferon effector function by inducing protein kinase R phosphorylation. Cell Host Microbe. (2009) 6:513–22. doi: 10.1016/j.chom.2009.11.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2009.11.004</ArticleId><ArticleId IdType="pmc">PMC2905238</ArticleId><ArticleId IdType="pubmed">20006840</ArticleId></ArticleIdList></Reference><Reference><Citation>Pfaller CK, George CX, Samuel CE. Adenosine deaminases acting on rna (Adars) and viral infections. Annu Rev Virol. (2021) 8:239–64. doi: 10.1146/annurev-virology-091919-065320</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-virology-091919-065320</ArticleId><ArticleId IdType="pubmed">33882257</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu G, Ma X, Wang Z, Wakae K, Yuan Y, He Z, et al. . Adenosine deaminase acting on rna-1 (Adar1) inhibits hepatitis B virus (Hbv) replication by enhancing microrna-122 processing. J Biol Chem. (2019) 294:14043–54. doi: 10.1074/jbc.RA119.007970</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.RA119.007970</ArticleId><ArticleId IdType="pmc">PMC6755794</ArticleId><ArticleId IdType="pubmed">31366735</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X, Ge X, Qin Y, Liu D, Chen C. Ifi30 is required for sprouting angiogenesis during caudal vein plexus formation in zebrafish. Front Physiol. (2022) 13:919579. doi: 10.3389/fphys.2022.919579</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2022.919579</ArticleId><ArticleId IdType="pmc">PMC9325957</ArticleId><ArticleId IdType="pubmed">35910561</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu C, Chen X, Guan G, Zou C, Guo Q, Cheng P, et al. . Ifi30 is a novel immune-related target with predicting value of prognosis and treatment response in glioblastoma. Onco Targets Ther. (2020) 13:1129–43. doi: 10.2147/ott.S237162</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/ott.S237162</ArticleId><ArticleId IdType="pmc">PMC7008640</ArticleId><ArticleId IdType="pubmed">32103982</ArticleId></ArticleIdList></Reference><Reference><Citation>Buetow KH, Meador LR, Menon H, Lu YK, Brill J, Cui H, et al. . High gilt expression and an active and intact mhc class ii antigen presentation pathway are associated with improved survival in melanoma. J Immunol. (2019) 203:2577–87. doi: 10.4049/jimmunol.1900476</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1900476</ArticleId><ArticleId IdType="pmc">PMC6832889</ArticleId><ArticleId IdType="pubmed">31591149</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang W, Zheng F, Yao T, Gong F, Zheng W, Yao N. Ifi30 as a prognostic biomarker and correlation with immune infiltrates in glioma. Ann Transl Med. (2021) 9:1686. doi: 10.21037/atm-21-5569</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/atm-21-5569</ArticleId><ArticleId IdType="pmc">PMC8667103</ArticleId><ArticleId IdType="pubmed">34988195</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou C, Wei Z, Zhang L, Yang Z, Liu Q. Systematically characterizing a-to-I rna editing neoantigens in cancer. Front Oncol. (2020) 10:593989. doi: 10.3389/fonc.2020.593989</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fonc.2020.593989</ArticleId><ArticleId IdType="pmc">PMC7758481</ArticleId><ArticleId IdType="pubmed">33363023</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan Y, Wang X, Li Y. Ifi30 expression predicts patient prognosis in breast cancer and dictates breast cancer cells proliferation via regulating autophagy. Int J Med Sci. (2021) 18:3342–52. doi: 10.7150/ijms.62870</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/ijms.62870</ArticleId><ArticleId IdType="pmc">PMC8364447</ArticleId><ArticleId IdType="pubmed">34400904</ArticleId></ArticleIdList></Reference><Reference><Citation>Majdoul S, Compton AA. Lessons in self-defence: inhibition of virus entry by intrinsic immunity. Nat Rev Immunol. (2022) 22:339–52. doi: 10.1038/s41577-021-00626-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-021-00626-8</ArticleId><ArticleId IdType="pmc">PMC8511856</ArticleId><ArticleId IdType="pubmed">34646033</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghosh A, Praefcke GJ, Renault L, Wittinghofer A, Herrmann C. How guanylate-binding proteins achieve assembly-stimulated processive cleavage of gtp to gmp. Nature. (2006) 440:101–4. doi: 10.1038/nature04510</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature04510</ArticleId><ArticleId IdType="pubmed">16511497</ArticleId></ArticleIdList></Reference><Reference><Citation>Li P, Jiang W, Yu Q, Liu W, Zhou P, Li J, et al. . Ubiquitination and degradation of gbps by a shigella effector to suppress host defence. Nature. (2017) 551:378–83. doi: 10.1038/nature24467</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature24467</ArticleId><ArticleId IdType="pubmed">29144452</ArticleId></ArticleIdList></Reference><Reference><Citation>Kreit M, Vertommen D, Gillet L, Michiels T. The interferon-inducible mouse apolipoprotein L9 and prohibitins cooperate to restrict theiler's virus replication. PLoS One. (2015) 10:e0133190. doi: 10.1371/journal.pone.0133190</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0133190</ArticleId><ArticleId IdType="pmc">PMC4510265</ArticleId><ArticleId IdType="pubmed">26196674</ArticleId></ArticleIdList></Reference><Reference><Citation>Siangphoe U, Archer KJ. Gene expression in hiv-associated neurocognitive disorders: A meta-analysis. J Acquir Immune Defic Syndr. (2015) 70:479–88. doi: 10.1097/qai.0000000000000800</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/qai.0000000000000800</ArticleId><ArticleId IdType="pubmed">26569176</ArticleId></ArticleIdList></Reference><Reference><Citation>Adão R, Guzik TJ. Inside the heart of Covid-19. Cardiovasc Res. (2020) 116:e59–61. doi: 10.1093/cvr/cvaa086</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/cvaa086</ArticleId><ArticleId IdType="pmc">PMC7184380</ArticleId><ArticleId IdType="pubmed">32266937</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu K, Chen Y, Li B, Li Y, Liang X, Lin H, et al. . Upregulation of apolipoprotein L6 improves tumor immunotherapy by inducing immunogenic cell death. Biomolecules. (2023) 13(3):415. doi: 10.3390/biom13030415</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom13030415</ArticleId><ArticleId IdType="pmc">PMC10046184</ArticleId><ArticleId IdType="pubmed">36979348</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Z, Lu H, Jiang Z, Pastuszyn A, Hu CA. Apolipoprotein L6, a novel proapoptotic bcl-2 homology 3-only protein, induces mitochondria-mediated apoptosis in cancer cells. Mol Cancer Res. (2005) 3:21–31.</Citation><ArticleIdList><ArticleId IdType="pubmed">15671246</ArticleId></ArticleIdList></Reference><Reference><Citation>Stellos K, Gatsiou A, Stamatelopoulos K, Perisic Matic L, John D, Lunella FF, et al. . Adenosine-to-inosine rna editing controls cathepsin S expression in atherosclerosis by enabling hur-mediated post-transcriptional regulation. Nat Med. (2016) 22:1140–50. doi: 10.1038/nm.4172</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.4172</ArticleId><ArticleId IdType="pubmed">27595325</ArticleId></ArticleIdList></Reference><Reference><Citation>Vlachogiannis NI, Tual-Chalot S, Zormpas E, Bonini F, Ntouros PA, Pappa M, et al. . Adenosine-to-inosine rna editing contributes to type I interferon responses in systemic sclerosis. J Autoimmun. (2021) 125:102755. doi: 10.1016/j.jaut.2021.102755</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2021.102755</ArticleId><ArticleId IdType="pmc">PMC8713031</ArticleId><ArticleId IdType="pubmed">34857436</ArticleId></ArticleIdList></Reference><Reference><Citation>Riese RJ, Wolf PR, Brömme D, Natkin LR, Villadangos JA, Ploegh HL, et al. . Essential role for cathepsin S in mhc class ii-associated invariant chain processing and peptide loading. Immunity. (1996) 4:357–66. doi: 10.1016/s1074-7613(00)80249-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s1074-7613(00)80249-6</ArticleId><ArticleId IdType="pubmed">8612130</ArticleId></ArticleIdList></Reference><Reference><Citation>Le Rouzic E, Mousnier A, Rustum C, Stutz F, Hallberg E, Dargemont C, et al. . Docking of hiv-1 vpr to the nuclear envelope is mediated by the interaction with the nucleoporin hcg1. J Biol Chem. (2002) 277:45091–8. doi: 10.1074/jbc.M207439200</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M207439200</ArticleId><ArticleId IdType="pubmed">12228227</ArticleId></ArticleIdList></Reference><Reference><Citation>Bell M, Schreiner S, Damianov A, Reddy R, Bindereif A. P110, a novel human U6 snrnp protein and U4/U6 snrnp recycling factor. EMBO J. (2002) 21:2724–35. doi: 10.1093/emboj/21.11.2724</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/emboj/21.11.2724</ArticleId><ArticleId IdType="pmc">PMC126028</ArticleId><ArticleId IdType="pubmed">12032085</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsiao YE, Bahn JH, Yang Y, Lin X, Tran S, Yang EW, et al. . Rna editing in nascent rna affects pre-mrna splicing. Genome Res. (2018) 28:812–23. doi: 10.1101/gr.231209.117</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gr.231209.117</ArticleId><ArticleId IdType="pmc">PMC5991522</ArticleId><ArticleId IdType="pubmed">29724793</ArticleId></ArticleIdList></Reference><Reference><Citation>Rieder LE, Reenan RA. The intricate relationship between rna structure, editing, and splicing. Semin Cell Dev Biol. (2012) 23:281–8. doi: 10.1016/j.semcdb.2011.11.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semcdb.2011.11.004</ArticleId><ArticleId IdType="pubmed">22178616</ArticleId></ArticleIdList></Reference><Reference><Citation>Booth BJ, Nourreddine S, Katrekar D, Savva Y, Bose D, Long TJ, et al. . Rna editing: expanding the potential of rna therapeutics. Mol Ther. (2023) 31:1533–49. doi: 10.1016/j.ymthe.2023.01.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ymthe.2023.01.005</ArticleId><ArticleId IdType="pmc">PMC9824937</ArticleId><ArticleId IdType="pubmed">36620962</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>